Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis-Reference-Cited by-同舟云学术

Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis

Published:2015-11 Issue:11 Volume:2 Page:1627-1633
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Song Taeksun,Lee Myungsun,Jeon Han-Seung,Park Yumi,Dodd Lori E.,Dartois Véronique,Follman Dean,Wang Jing,Cai Ying,Goldfeder Lisa C.,Olivier Kenneth N.,Xie Yingda,Via Laura E.,Cho Sang Nae,Barry Clifton E.,Chen Ray Y.^ORCID

Funder

National Institutes of Health

Ministry of Health and Welfare, Republic of Korea

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference34 articles.

1. Sequence and organization of the human mitochondrial genome;Anderson;Nature,1981

2. Biogenesis of mitochondria;Attardi;Annu. Rev. Cell Biol.,1988

3. Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections network survey;Beekmann;Diagn. Microbiol. Infect. Dis.,2008

4. Tedizolid: the first once-daily oxazolidinone class antibiotic;Burdette;Clin. Infect. Dis.,2015

5. Severe lactic acidosis associated with linezolid use in a patient with the mitochondrial DNA A2706G polymorphism;Carson;Pharmacotherapy,2007

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacology of emerging drugs for the treatment of multi-drug resistant tuberculosis;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-12

2. Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis;International Journal of Antimicrobial Agents;2024-10

3. Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial;Clinical Infectious Diseases;2024-08-28

4. Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen;Nature Communications;2024-08-25

5. Multidrug-resistant tuberculosis in children: A practical update on epidemiology, diagnosis, treatment and prevention;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-08